Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $15.36 USD
Change Today +0.25 / 1.65%
Volume 1.4M
CLDX On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald A. Pepin Ph.D.

Chief Business Officer and Senior Vice President,Celldex Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

59$1,225,027
As of Fiscal Year 2014

Background*

Dr. Ronald A. Pepin Ph.D. has been the Senior Vice President and Chief Business Officer of Celldex Therapeutics, Inc. since July 2011. Dr. Pepin served as a Senior Vice President of Business Development at Medarex Inc., from 2000 to September 2009. Dr. Pepin joined Medarex Inc. in August 2000 as Vice President of Business Development. Dr. Pepin served as Executive Director of External Science and Technology at the Bristol-Myers Squibb Company. Dr. Pepin served as a Vice ...

Read Full Background

Corporate Headquarters*

Perryville III Building
Hampton, New Jersey 08827

United States

Phone: 908-200-7500
Fax: 908-454-1911

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Georgetown University
Unknown/Other Education
Tufts University

Other Affiliations*

Annual Compensation*

Salary$321,481
Bonus$98,083
Total Annual Compensation$419,564

Stock Options*

All Other Compensation$6,425
Exercisable Options160,000
Exercisable Options Value$1,885,819
Unexercisable Options212,000
Unexercisable Options Value$1,329,281
Total Value of Options$3,215,100
Total Number of Options372,000

Total Compensation*

Total Annual Cash Compensation$425,989
Total Short Term Compensation$419,564
Other Long Term Compensation$6,425
Total Calculated Compensation$1,225,027
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLDX:US $15.36 USD +0.25

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLDEX THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.